U.S. market Closed. Opens in 3 hours 13 minutes

VTYX | Ventyx Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue941.00KN/AN/A470.00KN/A30.00KN/AN/AN/A
Gross Profit-941.00KN/AN/A-470.00KN/A-30.00KN/AN/AN/A
Operating Expenses207.99M196.22M113.14M113.14M67.15M67.15M7.05M7.05M4.18M
Selling, General & Admin32.23M32.29M25.40M25.40M8.67M8.67M684.00K684.00K628.00K
Research & Development175.77M163.93M87.74M87.74M58.48M58.48M6.37M6.37M3.55M
Other Operating Expenses0158.00K41.00K41.00K-5.45M-5.45M-1.00K-1.00K-1.00K
Operating Income-207.99M-196.22M-113.14M-113.14M-67.15M-67.15M-7.05M-7.05M-4.18M
Other Expenses / Income15.03M158.00K4.71M4.71M-16.60M-16.60M-21.12M-21.12M-147.00K
Before Tax Income-192.96M-181.42M-108.43M-108.43M-83.75M-83.75M-28.17M-28.17M-4.33M
Income Tax ExpensesN/A-9.93M-470.00K-470.00K-5.38M-5.38M358.00K358.00K146.00K
Net Income-192.96M-181.42M-107.96M-107.96M-78.37M-78.37M-28.53M-28.53M-4.47M
Interest ExpensesN/AN/A-4.71M-4.71M99.00K99.00K358.00K358.00K146.00K
Basic Shares Outstanding58.54MN/A52.47M52.47M12.83M50.41M21.12M50.30M50.30M
Diluted Shares Outstanding58.54MN/A52.47M52.47M12.83M50.41M21.12M50.30M50.30M
EBITDA-207.84M-190.82M-108.43M-108.43M-72.60M-72.60M-7.05M-7.05M-4.18M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-192.96M-191.35M-113.14M-113.14M-83.65M-83.65M-27.82M-27.82M-4.18M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙